Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.

Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, de Souza Campos VH, Ferreira TS, Quirino Dos Santos CV, Ribeiro Nogueira AM, Figueiredo Guimaraes Almeida AP, Cançado Monteiro Savassi L, de Figueiredo Neto AD, Bitarães C, Cruz Milagres A, Diniz Callegari E, Campos Simplicio MI, Barra Ribeiro L, Oliveira R, Harari O, Wilson LA, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Guyatt GH, Rayner CR, Boulware DR, Ezer N, Lee TC, McDonald EG, Bafadhel M, Butler C, Rodrigues Silva J, Dybul M, Mills EJ, TOGETHER Investigators

Open source

DOI: 10.7326/m22-3305
Published: 2023 May
Container: Annals of internal medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.7326/m22-3305,
  title = {Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.},
  author = {Reis G and Dos Santos Moreira Silva EA and Medeiros Silva DC and Thabane L and de Souza Campos VH and Ferreira TS and Quirino Dos Santos CV and Ribeiro Nogueira AM and Figueiredo Guimaraes Almeida AP and Cançado Monteiro Savassi L and de Figueiredo Neto AD and Bitarães C and Cruz Milagres A and Diniz Callegari E and Campos Simplicio MI and Barra Ribeiro L and Oliveira R and Harari O and Wilson LA and Forrest JI and Ruton H and Sprague S and McKay P and Guo CM and Guyatt GH and Rayner CR and Boulware DR and Ezer N and Lee TC and McDonald EG and Bafadhel M and Butler C and Rodrigues Silva J and Dybul M and Mills EJ and TOGETHER Investigators},
  year = {2023},
  journal = {Annals of internal medicine},
  doi = {10.7326/m22-3305},
  url = {https://doi.org/10.7326/m22-3305}
}

RIS

TY  - JOUR
TI  - Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.
AU  - Reis G
AU  - Dos Santos Moreira Silva EA
AU  - Medeiros Silva DC
AU  - Thabane L
AU  - de Souza Campos VH
AU  - Ferreira TS
AU  - Quirino Dos Santos CV
AU  - Ribeiro Nogueira AM
AU  - Figueiredo Guimaraes Almeida AP
AU  - Cançado Monteiro Savassi L
AU  - de Figueiredo Neto AD
AU  - Bitarães C
AU  - Cruz Milagres A
AU  - Diniz Callegari E
AU  - Campos Simplicio MI
AU  - Barra Ribeiro L
AU  - Oliveira R
AU  - Harari O
AU  - Wilson LA
AU  - Forrest JI
AU  - Ruton H
AU  - Sprague S
AU  - McKay P
AU  - Guo CM
AU  - Guyatt GH
AU  - Rayner CR
AU  - Boulware DR
AU  - Ezer N
AU  - Lee TC
AU  - McDonald EG
AU  - Bafadhel M
AU  - Butler C
AU  - Rodrigues Silva J
AU  - Dybul M
AU  - Mills EJ
AU  - TOGETHER Investigators
PY  - 2023
JO  - Annals of internal medicine
DO  - 10.7326/m22-3305
UR  - https://doi.org/10.7326/m22-3305
ER  -

APA

G, R., EA, D. S. M. S., DC, M. S., L, T., VH, D. S. C., TS, F., CV, Q. D. S., AM, R. N., AP, F. G. A., L, C. M. S., AD, D. F. N., C, B., A, C. M., E, D. C., MI, C. S., L, B. R., R, O., O, H., LA, W., JI, F., H, R., S, S., P, M., CM, G., GH, G., CR, R., DR, B., N, E., TC, L., EG, M., M, B., C, B., J, R. S., M, D., EJ, M., & Investigators, T. (2023). Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.. Annals of internal medicine. https://doi.org/10.7326/m22-3305

Source records

pubmed · retrieved 2026-09-26T02:08:33.549Z